557 related articles for article (PubMed ID: 20222120)
1. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
2. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice.
Zhang Y; Brenner M; Yang WL; Wang P
Lab Invest; 2015 May; 95(5):480-90. PubMed ID: 25751740
[TBL] [Abstract][Full Text] [Related]
4. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
5. 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.
Fitzpatrick LR; Deml L; Hofmann C; Small JS; Groeppel M; Hamm S; Lemstra S; Leban J; Ammendola A
Inflamm Bowel Dis; 2010 Oct; 16(10):1763-77. PubMed ID: 20310011
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
7. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
8. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
9. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
10. 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.
Clapper ML; Gary MA; Coudry RA; Litwin S; Chang WC; Devarajan K; Lubet RA; Cooper HS
Inflamm Bowel Dis; 2008 Oct; 14(10):1341-7. PubMed ID: 18452197
[TBL] [Abstract][Full Text] [Related]
11. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
12. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus carrying thymosin β
Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
[TBL] [Abstract][Full Text] [Related]
14. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
15. Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation.
He J; Song Y; Li G; Xiao P; Liu Y; Xue Y; Cao Q; Tu X; Pan T; Jiang Z; Cao X; Lai L; Wang Q
J Clin Invest; 2019 Jun; 129(9):3877-3893. PubMed ID: 31246581
[TBL] [Abstract][Full Text] [Related]
16. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.
Alex P; Zachos NC; Nguyen T; Gonzales L; Chen TE; Conklin LS; Centola M; Li X
Inflamm Bowel Dis; 2009 Mar; 15(3):341-52. PubMed ID: 18942757
[TBL] [Abstract][Full Text] [Related]
17. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.
Wei X; Liang J; Liu J; Dai Y; Leng X; Cheng Y; Chi L
J Ethnopharmacol; 2024 May; 326():117995. PubMed ID: 38428656
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice.
Giner E; Recio MC; Ríos JL; Cerdá-Nicolás JM; Giner RM
Mol Nutr Food Res; 2016 Feb; 60(2):242-55. PubMed ID: 26502315
[TBL] [Abstract][Full Text] [Related]
19. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
20. Glutathione transferase Omega 1 confers protection against azoxymethane-induced colorectal tumour formation.
Tummala P; Rooke M; Dahlstrom JE; Takahashi S; Casarotto MG; Fernando N; Hughes MM; O'Neill LAJ; Board PG
Carcinogenesis; 2021 Jun; 42(6):853-863. PubMed ID: 33564842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
